Caregen Co Ltd
KOSDAQ:214370
Caregen Co Ltd
Interest Income Expense
Caregen Co Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Interest Income Expense
₩6.6B
|
CAGR 3-Years
30%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
Yuhan Corp
KRX:000100
|
Interest Income Expense
₩45.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Interest Income Expense
-₩11.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Interest Income Expense
-₩21.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Interest Income Expense
-₩12.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Interest Income Expense
-₩7.3B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-8%
|
See Also
What is Caregen Co Ltd's Interest Income Expense?
Interest Income Expense
6.6B
KRW
Based on the financial report for Mar 31, 2024, Caregen Co Ltd's Interest Income Expense amounts to 6.6B KRW.
What is Caregen Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
20%
Over the last year, the Interest Income Expense growth was 50%. The average annual Interest Income Expense growth rates for Caregen Co Ltd have been 30% over the past three years , 20% over the past five years .